Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/1374

Title:	Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma
Authors:	Wen-Kai Weng Levy, R.
Issue Date:	Sep-2001
Journal Volume:	98
Journal Issue:	5
Source:	Blood
URI:	http://scholars.ntou.edu.tw/handle/123456789/1374
ISSN:	0006-4971
DOI:	10.1182/blood.V98.5.1352 ://WOS:000170685000014
Appears in Collections:	河海工程學系

Show full item record

Last Week
0

Last month
0

checked on Oct 13, 2022

Check

DSpace CRIS